ATHX to present at Cell & Gene Meeting on the Mesa
CLEVELAND, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the annual Cell & Gene Meeting on the Mesa to be held October 2nd -4th in Carlsbad, California.
Dr. Van Bokkelen will provide a brief overview of the Company’s mission and its therapeutic platform, MultiStem® cell therapy. The presentation will include information on the critical care indications in the Company’s progressing clinical pipeline, including the ongoing Phase 3 trial of MultiStem cell therapy for the treatment of ischemic stroke that has received Fast Track and Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration and positive scientific advice from the European Medicines Agency, and is being conducted under a Special Protocol Assessment. The presentation will also cover the Company’s Acute Respiratory Distress Syndrome (“ARDS”) program, which has received Fast Track designation from the U.S. Food and Drug Administration.
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference featuring more than 80 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies, as well as over 100 panelists and featured speakers.
The following are specific details regarding the Athersys presentation at the conference:
Event: Athersys Corporate Presentation
Date: Thursday, October 3, 2019
Time: 5:45 p.m. Pacific Time
Location: BlueRock Therapeutics Ballroom, Park Hyatt Aviara Resort, 7100 Aviara Resort Dr., Carlsbad, CA 92011
A live video webcast of all company presentations will be available at: http://www.meetingonthemesa.com/webcast and will also be published on the conference website and the Athersys website shortly after the event.
Please visit www.meetingonthemesa.com for full information, including registration. Complimentary attendance at this event is available for credentialed investors and members of the media, only. Investors should contact Laura Parsons at firstname.lastname@example.org, and interested media should contact Lyndsey Scull at email@example.com.